Science Explorer Interactive view Map
Company · Lyon · France

Erytech Pharma (France)

Research works
61
▼ 8% vs 2013–17
Citations
707
11.6 per fractional work
Top-10% rate
11.8%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Erytech Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.16× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 3.49× its world share, 1 worksImmunology and Micro…Neuroscience: 0.54× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.90× its world share, 0 worksPharmacology, Toxico…Engineering: 0.28× its world share, 1 worksEngineeringHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 2.63× its world share, 8 worksMedicineNursing: 1.30× its world share, 0 worksNursingworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.2×. Every wedge is a field page.

Who are the top researchers at Erytech Pharma (France)?

Ranked on the composite score, Iman El‐Hariry lead among researchers whose main affiliation is Erytech Pharma (France).

  1. 1 Iman El‐Hariry France · #1,610,946 worldwide 12 citations · 15 works
All ranked researchers at Erytech Pharma (France)

Which keywords describe research at Erytech Pharma (France)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Tumor Regression, Tumor Microenvironment, Bacterial Therapy, Tumor Targeting, Prognostic Factors and Acute Lymphoblastic Leukemia.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy6▲ 16×6 topics
  2. Gene Therapy6▲ 35×4 topics
  3. Tumor Regression4▲ 84×2 topics
  4. Tumor Microenvironment4▲ 19×5 topics
  5. Bacterial Therapy4▲ 141×1 topic
  6. Tumor Targeting4▲ 47×1 topic
  7. Prognostic Factors4▲ 13×3 topics
  8. Acute Lymphoblastic Leukemia3▲ 149×1 topic
  9. Childhood Cancer3▲ 149×1 topic
  10. Oxidative Stress3▲ 3.0×12 topics
  11. Inflammatory Diseases3▲ 43×2 topics
  12. Metabolic Health3▲ 40×3 topics
  13. Erythropoiesis3▲ 55×2 topics
  14. Apoptosis3▲ 12×5 topics
  15. Gut Microbiota3▲ 13×1 topic
  16. Microbial Communities3▲ 13×1 topic
  17. Parathyroid Hormone3▲ 43×2 topics
  18. Cancer2▲ 3.0×4 topics
  19. Cancer Immunotherapy2▲ 29×2 topics
  20. Piezo12▲ 83×1 topic
  21. Piezo22▲ 83×1 topic
  22. Chemotherapy2▲ 4.4×5 topics
  23. Innate Immunity2▲ 8.7×2 topics
  24. Dendritic Cells2▲ 26×1 topic
  25. Immunity2▲ 8.8×1 topic
  26. HIF-12▲ 40×1 topic
  27. Hypoparathyroidism2▲ 130×1 topic
  28. NK Cell Recognition2▲ 27×1 topic
  29. Natural Killer Cells2▲ 27×1 topic
  30. Pancreatic Cancer2▲ 23×2 topics
  31. Thyroid Surgery2▲ 130×1 topic
  32. Warburg Effect2▲ 40×1 topic
  33. Enzyme Regulation1▲ 47×2 topics
  34. Gemcitabine1▲ 36×1 topic
  35. Parkinson's Disease1▲ 10.0×2 topics
  36. Surgical Complications1▲ 31×1 topic
  37. Enzyme Replacement Therapy1▲ 81×1 topic
  38. Lysosomal Storage Disorders1▲ 112×1 topic
  39. Metabolic Disorders1▲ 12×3 topics
  40. Circular Economy1▲ 9.5×2 topics

Which research topics does Erytech Pharma (France) publish most on?

By volume in 2022–2025: Gut microbiota and health, Cancer Research and Treatments, Thyroid and Parathyroid Surgery and Pancreatic and Hepatic Oncology Research.

  1. 1 Gut microbiota and health Molecular Biology 2 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 Thyroid and Parathyroid Surgery Surgery 1 works
  4. 4 Pancreatic and Hepatic Oncology Research Oncology 1 works
  5. 5 3D Printing in Biomedical Research Biomedical Engineering 1 works
  6. 6 Parathyroid Disorders and Treatments Nephrology 1 works
  7. 7 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Ion Transport and Channel Regulation Molecular Biology 0 works
  9. 9 Biochemical Acid Research Studies Biochemistry 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.7%not open70.3%

World: 28% of research is openly available.

with international co-authors29.8%domestic only70.2%

World: 19% is written across borders.

How has Erytech Pharma (France)'s research output changed?

Output in 2018–2022 was 8% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lyon

All research institutions in Lyon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.